MENU
+Compare
POAI
Stock ticker: NASDAQ
AS OF
Jul 11 closing price
Price
$0.79
Change
-$0.01 (-1.25%)
Capitalization
9.22M

POAI Predictive Oncology Forecast, Technical & Fundamental Analysis

Predictive Oncology Inc functions in the healthcare domain... Show more

POAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for POAI with price predictions
Jul 11, 2025

POAI's RSI Indicator sits in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where POAI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where POAI advanced for three days, in of 225 cases, the price rose further within the following month. The odds of a continued upward trend are .

POAI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on POAI as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for POAI turned negative on June 20, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 50-day moving average for POAI moved below the 200-day moving average on June 16, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where POAI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for POAI entered a downward trend on July 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.792) is normal, around the industry mean (24.348). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (4.955) is also within normal values, averaging (42.660).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. POAI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. POAI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
POAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a company, which engages in the manufacture and distribution of healthcare products, and provision of related services.

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
2915 Commers Drive
Phone
+1 651 389-4800
Employees
34
Web
https://www.predictive-oncology.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GIFI7.190.14
+1.99%
Gulf Island Fabrication
TSBX0.37N/A
-0.11%
Turnstone Biologics Corp
ATEX23.95-0.17
-0.73%
Anterix
MTRN86.11-0.89
-1.02%
Materion Corp
GDDY167.86-2.91
-1.70%
GoDaddy

POAI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, POAI has been loosely correlated with MBOT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if POAI jumps, then MBOT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POAI
1D Price
Change %
POAI100%
-1.25%
MBOT - POAI
37%
Loosely correlated
+4.80%
TNON - POAI
31%
Poorly correlated
-6.42%
APDN - POAI
28%
Poorly correlated
-3.56%
AIMD - POAI
27%
Poorly correlated
-5.10%
DHAI - POAI
27%
Poorly correlated
-4.09%
More